PEPFAR FY 2025 Monitoring, Evaluation, and Results Data Reveals First Insights into Program Performance

When the State Department released the Fiscal Year 2025 fourth quarter Monitoring, Evaluation, and Reporting (MER) data for PEPFAR on April 17, 2026, it marked the first program-level glimpse into how the U.S. Global HIV/AIDS initiative has operated amid significant policy shifts since the start of the second Trump administration. That data, covering July 1 through September 30, 2025, revealed that 103,000 pregnant and breastfeeding women initiated pre-exposure prophylaxis (PrEP) through PEPFAR support during that quarter—a figure that more than doubled the 43,000 recorded in the same period of fiscal year 2024. For someone tracking these trends from a community health center in Austin, Texas, where the intersection of East 12th Street and Chicon Street has long been a hub for HIV outreach and testing, this national statistic isn’t just a number—it reflects a tangible shift in prevention access that could directly influence how local clinics allocate resources, train staff, and engage with populations most vulnerable to new infections.

Digging deeper into the context behind these numbers, the April 2026 KFF analysis of the same MER release emphasized that this Q4 data represents the first verifiable program output since PEPFAR’s data platform was temporarily removed in early 2025 and restored without FY 2025 quarters 1–3 due to reporting challenges tied to the broader foreign aid review. The analysis noted that since the administration transition, PEPFAR has undergone a temporary stop-work order, cancellation of numerous awards, and a strategic pivot under the new “America First Global Health Strategy”—which prioritizes bilateral agreements, frontline commodities like antiretrovirals and test kits, and a move away from disease-specific silos toward integrated service delivery. Yet despite these upheavals, the Q4 PrEP initiation surge suggests that core prevention pipelines, particularly for maternal health, remained operational and even expanded in reach during the final months of the fiscal year. This resilience contrasts with early modeling that forecasted steep declines in service coverage, hinting that frontline implementers—whether through state health departments, community-based organizations, or contracted partners—may have adapted swiftly to maintain critical pipelines.

In Austin, where organizations like Austin Public Health’s HIV Prevention Program, the People’s Community Clinic, and AIDS Services of Austin (ASA) have historically relied on a mix of federal, state, and local funding to deliver PrEP navigation, rapid testing, and linkage-to-care services, such national trends prompt immediate local questions. Are clinics in Travis County seeing similar increases in PrEP starts among pregnant individuals? How are community health workers adjusting counseling protocols amid shifting federal guidelines? And what does this signify for the city’s goal of ending the HIV epidemic by 2030, especially in neighborhoods like East Austin and Rundberg, where late-stage diagnoses have historically disproportionately affected Black and Latino residents? The MER data doesn’t break down results by zip code, but it does confirm that PEPFAR-supported PrEP distribution continued at scale nationally—a signal that local providers may still be able to count on certain commodity streams, even as they navigate an evolving grant landscape.

Given my background in global health policy and frontline implementation, if this trend impacts you in Austin—whether you’re a clinician at CommUnityCare, a case manager at Outreach Community Center, or a peer educator working along South Congress—here are the three types of local professionals you need to connect with right now.

First, seek out HIV Prevention Navigators with PrEP-specific expertise. These aren’t just general outreach workers; look for individuals certified in trauma-informed counseling, experienced in navigating Medicaid and Ryan White eligibility, and deeply familiar with Austin’s geographic barriers to care—like transit deserts in Southeast Austin or language access needs in North Lamar. They should demonstrate proven success in linking pregnant individuals to PrEP within 30 days of identification and maintain active relationships with OB-GYN providers at Dell Seton and Women’s Hospital of Austin.

Second, prioritize Community-Based Pharmacy Technicians embedded in safety-net clinics. In a climate where frontline commodity access is emphasized, these professionals are critical. Find those who manage inventory for tenofovir disoproxil fumarate/emtricitabine (TDF/FTC) and cabotegravir (CAB-LA) under 340B or patient assistance programs, who can explain dosing schedules clearly to patients with low health literacy, and who coordinate directly with labs like Quest or LabCorp for timely renal and STI screening. Their value multiplies when they operate within trusted spaces like the People’s Community Clinic on East Cesar Chavez or the Vicente Gonzalez Sr. Clinic, reducing stigma and improving adherence.

Third, engage Local Data Liaisons who bridge clinical sites and public health reporting. With PEPFAR’s MER system under scrutiny and local agencies like Austin Public Health increasingly responsible for monitoring outcomes, you need professionals who understand both HL7 messaging and the practical realities of frontline documentation. Look for individuals experienced in submitting data to Texas’ enhanced HIV/AIDS Reporting System (eHARS), skilled in using platforms like REDCap or CommCare for real-time tracking, and capable of translating clinic-level trends into actionable insights for grant reports or city council briefings—especially those who’ve worked with the Dell Medical School’s Population Health team or the Central Texas HIV Planning Council.

Ready to find trusted professionals? Browse our complete directory of top-rated Global Health Policy,Antiretrovirals,HIV Testing,PEPFAR experts in the Austin area today.